김
김재관 Directeur Exécutif
Other M
Discover the complete record of transactions filed by 김재관, Directeur Exécutif. Insider active across 2 companies, notably 유비벨록스. In total, 115 filings have been logged. Activity tracked since 7 April 2026. The latest transaction was disclosed on 28 April 2026 (Purchase). Regulator: DART (FSS). The full history is free.
Declarations 115 total
● Executives · 26 May 2026 (filed) · 동구바이오제약 ● Executives · 13 May 2026 (filed) · 동구바이오제약 ● 상무이사 · Executives · 22 Apr 2026 · 유비벨록스 756 shares @ ₩5,070.00 0.0000% mcap 100.0% of flow Share DART:20260428000459 Ideal exit: 17 Jan 2027 (T+270) ● 전무이사 · Executives · 22 Apr 2026 · 유비벨록스 943 shares @ ₩5,070.00 0.0000% mcap 100.0% of flow Share DART:20260428000443 Ideal exit: 17 Jan 2027 (T+270) ● 전무이사 · Executives · 22 Apr 2026 · 유비벨록스 203 shares @ ₩5,070.00 0.0000% mcap 100.0% of flow Share DART:20260428000410 Ideal exit: 17 Jan 2027 (T+270) ● 전무이사 · Executives · 22 Apr 2026 · 유비벨록스 995 shares @ ₩5,070.00 0.0000% mcap 100.0% of flow Share DART:20260428000437 Ideal exit: 17 Jan 2027 (T+270) ● Executives · 28 Apr 2026 (filed) · 유비벨록스 56,265 shares DART:20260428000489 Ideal exit: 23 Jan 2027 (T+270) ● 대표이사 · Executives · 22 Apr 2026 · 유비벨록스 36,406 shares @ ₩5,070.00 0.0001% mcap 100.0% of flow Share DART:20260428000466 Ideal exit: 17 Jan 2027 (T+270) ● 전무이사 · Executives · 17 Apr 2026 · 팅크웨어 122 shares @ ₩8,320.00 0.0000% mcap 100.0% of flow Share DART:20260423000566 Ideal exit: 12 Jan 2027 (T+270) ● Executives · 23 Apr 2026 (filed) · 팅크웨어 157,303 shares DART:20260423000640 Ideal exit: 18 Jan 2027 (T+270) ● - · Executives · 17 Apr 2026 · 팅크웨어 119,749 shares @ ₩8,320.00 0.0006% mcap 100.0% of flow Share DART:20260423000627 Ideal exit: 12 Jan 2027 (T+270) ● 대표이사 · Executives · 17 Apr 2026 · 팅크웨어 3,472 shares @ ₩8,320.00 0.0000% mcap 100.0% of flow Share DART:20260423000611 Ideal exit: 12 Jan 2027 (T+270) ● - · Executives · 17 Apr 2026 · 팅크웨어 42,960 shares @ ₩8,320.00 0.0002% mcap 100.0% of flow Share DART:20260422000083 Ideal exit: 12 Jan 2027 (T+270) ● Executives · 7 Apr 2026 (filed) · 팅크웨어 620 shares DART:20260407000424 Ideal exit: 2 Jan 2027 (T+270) ● 전무이사 · Executives · 6 Apr 2026 (filed) · 팅크웨어 Share DART:20260406002591 Ideal exit: 1 Jan 2027 (T+270) ● 전무이사 · Executives · 6 Apr 2026 (filed) · 팅크웨어 Share DART:20260406002689 Ideal exit: 1 Jan 2027 (T+270) ● Executives · 2 Apr 2026 (filed) · 동구바이오제약 34,000 shares DART:20260402002932 ● Executives · 16 Mar 2026 (filed)
● Executives · 16 Mar 2026 (filed)
● Executives · 16 Mar 2026 (filed)
● Executives · 10 Mar 2026 (filed)
● Executives · 27 Feb 2026 (filed) · 유비벨록스 ● Executives · 27 Feb 2026 (filed) · 팅크웨어 ● Executives · 20 Jan 2026 (filed)
● Executives · 12 Jan 2026 (filed)
25 of 115 declarations
Load more (90 remaining) About 김재관 Kim Jae-gwan is an Executive Director at UbiVelox, where he oversees operations and investment strategies. His role is essential to ensure the company's growth and profitability.